ITI School in Hemophilia in Malmö, Sweden
The Hemostasis and Thrombosis Research Society (HTRS) has been commissioned by Octapharma to recruit and select up to three U.S. hematologists to attend ITI School in Hemophilia from January 17-18, 2020, in Malmö, Sweden. This educational course is sponsored by Octapharma and provided by Lund University and the Malmö Centre for Thrombosis and Haemostasis at Skåne University Hospital in collaboration with international hemophilia experts.
HTRS is now accepting applications from U.S. hematologists who can demonstrate a need for further training in the best approaches and care of hemophilia patients who develop inhibitors. Participants should be hematologists treating hemophilia with previous experience conducting ITI and affiliated with a hemophilia center. Good English skills are required. Successful applicants will travel to Malmö, Sweden to take part in this educational course on January 17-18, 2020. Please CLICK HERE for complete details.
This course is based on outlined lectures and interactive authentic case studies in accordance with case methodology. The course includes an examination addressing main messages. Participants will receive a course binder containing the course content so that the message can be shared with their own departments. LIPUS (Institute for the Professional Development of Physicians in Sweden) will review the course (www.lipus.se). CME (Continuing Medical Education) application pending (EACCME).
The 2-day course begins Friday, January 17 at 8:30 a.m. with an introduction and proceeds through a full agenda including lunch and culminating with the Octapharma Symposium and dinner. On Saturday, January 18, lectures will begin at 8:30 a.m. with lectures, presentations, case studies, and the opportunity for interactive discussion, concluding with an exam and course evaluation by 4:30 p.m.